Tessa Therapeutics is a biotechnology company specializing in the research, clinical development, and commercialization of cancer immunotherapy treatments. The Company is engaged in employing Virus-Specific T cells to treat cancer, and conducting US FDA-registered Phase III T cell therapy trial in NPC, or any cancer indication.